Lysostaphin - Bharat Biotechnologies

Drug Profile

Lysostaphin - Bharat Biotechnologies

Alternative Names: BBIL-5

Latest Information Update: 14 Dec 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bharat Biotech
  • Class Antibacterials; Metalloendopeptidases
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Staphylococcal infections

Most Recent Events

  • 06 Jun 2016 Phase-II/III clinical trials in Staphylococcal infections in India (Topical) (CTRI2016-09-007277)
  • 08 Sep 2015 Phase-II development for Staphylococcal infections is ongoing in India
  • 15 Nov 2011 Phase-II clinical trials in Staphylococcal infections in India (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top